Ambady Ramachandran

1985–2025 年に発表

88
論文数
23,741
被引用数
68
h 指数
87
i10 指数

被引用数

Ambady Ramachandran の年別被引用数1985 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 4 件1990 年: 被引用 3 件1991 年: 被引用 1 件1992 年: 被引用 1 件1994 年: 被引用 5 件1995 年: 被引用 4 件1996 年: 被引用 6 件1997 年: 被引用 9 件1998 年: 被引用 7 件1999 年: 被引用 15 件2000 年: 被引用 24 件2001 年: 被引用 28 件2002 年: 被引用 29 件2003 年: 被引用 59 件2004 年: 被引用 86 件2005 年: 被引用 99 件2006 年: 被引用 113 件2007 年: 被引用 132 件2008 年: 被引用 122 件2009 年: 被引用 125 件2010 年: 被引用 130 件2011 年: 被引用 140 件2012 年: 被引用 145 件2013 年: 被引用 124 件2014 年: 被引用 162 件2015 年: 被引用 126 件2016 年: 被引用 130 件2017 年: 被引用 190 件2018 年: 被引用 287 件2019 年: 被引用 885 件2020 年: 被引用 836 件2021 年: 被引用 673 件2022 年: 被引用 570 件2023 年: 被引用 442 件2024 年: 被引用 689 件2025 年: 被引用 354 件2026 年: 被引用 10 件1986 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,745 件、この内訳の 14.7%イギリス: 引用元論文 1,046 件、この内訳の 8.8%中国: 引用元論文 966 件、この内訳の 8.1%インド: 引用元論文 847 件、この内訳の 7.1%オーストラリア: 引用元論文 511 件、この内訳の 4.3%カナダ: 引用元論文 385 件、この内訳の 3.2%ドイツ: 引用元論文 362 件、この内訳の 3%イタリア: 引用元論文 355 件、この内訳の 3%デンマーク: 引用元論文 244 件、この内訳の 2.1%スペイン: 引用元論文 236 件、この内訳の 2%日本: 引用元論文 225 件、この内訳の 1.9%フランス: 引用元論文 219 件、この内訳の 1.8%
0%14.7%その他 40%

分野

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Health Professions4.8%
  • Business, Management and Accounting1.3%
  • Nursing1.2%
  • Psychology0.9%
  • その他5.7%

トピック

  • Diabetes, Cardiovascular Risks, and Lipoproteins9%
  • Diabetes Treatment and Management8.4%
  • Diabetes Management and Research4.3%
  • Diabetes Management and Education3.8%
  • Metabolism, Diabetes, and Cancer3.3%
  • Pancreatic function and diabetes2.6%
  • その他68.6%

共著者

全論文

検索で開く
  1. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 2,143

  2. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , K Abdul Kadir, NM Abu-Rmeileh, Benjamín Acosta-Cázares, Robert J. Adams, Wichai Aekplakorn, CA Aguilar-Salinas, Charles Agyemang, Alireza Ahmadvand, AR Al-Othman, Ala’a Alkerwi, Philippe Amouyel, Antoinette Amuzu, L. B. Andersen, SA Anderssen, RM Anjana, Hajer Aounallah-Skhiri, Tahir Aris, Nimmathota Arlappa, Dominique Arveiler, Félix Assah, Mária Avdičová, Fereidoun Azizi, Nagalla Balakrishna, Piotr Bandosz, Carlo M. Barbagallo, Alberto Barceló, Anwar Batieha, Louise A. Baur, Romdhane Hb, Mikhail Benet Rodríguez, Antonio Bernabé‐Ortiz, Shruthi K. Bharadwaj, Bhargava Sk, Yuhai Bi, Peter Bjerregaard, Espen Bjertness, MB Bjertness, Cecilia Björkelund, Anneke Blokstra, Simona Bo, B. O. Boehm, CP Boissonnet, Pascal Bovet, Imperia Brajkovich, Juergen Breckenkamp, Hermann Brenner, Lizzy M. Brewster, GR Brian, Graziella Bruno, Anna Bugge, Antonio Cabrera de León, Günay Can, AP Cândido, Vincenzo Capuano, Axel C. Carlsson, Joana Carvalho, Felipe F. Casanueva, JP Casas, CA Caserta, Katia Castetbon, S Chamukuttan, Nish Chaturvedi, C-J Chen, F Chen, S Chen, Ching‐Yu Cheng, Angela Chetrit, S-T Chiou, Yoonho Cho, Jerzy Chudek ほか 414 名 - The Lancet 2016 被引用: 4,381

  3. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Constance Wou, Ronald C W Ma, Maria I Schmidt, Ambady Ramachandran, Yutaka Seino, Peter H Bennett, Brian Oldenburg, Juan José Gagliardino, Andrea O Y Luk, Philip M Clarke, Graham D Ogle, Melanie J Davies, Rury R Holman, Edward W Gregg - The Lancet 2020 被引用: 737

  4. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)

    著者: , , , , , , - Diabetologia 2006 被引用: 1,880

  5. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

    著者: , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2017 被引用: 592

  6. COVID-19 and metabolic disease: mechanisms and clinical management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giatgen A. Spinas, Felix Beuschlein, Rüdiger Landgraf, Francesco Rubino, Geltrude Mingrone, Stefan R. Bornstein - The Lancet Diabetes & Endocrinology 2021 被引用: 250

  7. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hyeon Chang Kim, Tiina Laatikainen, Avula Laxmaiah, Jean Claude Mbanya, K.M. Venkat Narayan, Ambady Ramachandran, Alisha N. Wade, Tomasz Zdrojewski, Mohsen Abbasi‐Kangevari, Hanan F Abdul Rahim, Niveen Abu-Rmeileh, Shalkar Adambekov, Robert J. Adams, Wichai Aekplakorn, Imelda Angeles‐Agdeppa, Javad Aghazadeh-Attari, Charles Agyemang, Ali Ahmadi, Naser Ahmadi, Nastaran Ahmadi, Soheir H. Ahmed, Kamel Ajlouni, Halima Al-Hinai, Badreya Al‐Lahou, Jawad Al‐Lawati, Deena Alasfoor, Nawal M. Al Qaoud, Monira Alarouj, Fadia AlBuhairan, Shahla AlDhukair, M. Aldwairji, Mohamed M. Ali, Farbod Alinezhad, Abdullah Alkandari, Husam Alomirah, Eman Aly, Deepak Amarapurkar, Lars Bo Andersen, Sigmund A. Anderssen, Susana Andrade, Alireza Ansari‐Moghaddam, Hajer Aounallah-Skhiri, Tahir Aris, Nimmathota Arlappa, Krishna K. Aryal, Félix Assah, Batyrbek Assembekov, Juha Auvinen, Mária Avdičová, Kishwar Azad, Mohsen Azimi–Nezhad, Fereidoun Azizi, Flora Bacopoulou, Nagalla Balakrishna, Mohamed Bamoshmoosh, Maciej Banach, Piotr Bandosz, José R. Banegas, Carlo M. Barbagallo, Alberto Barceló, Maja Baretić, Lena Barrera, Abdul Basit, Anwar Batieha, Aline P. Batista, Louise A. Baur, Belavendra Antonisamy, Habiba Ben Romdhane, Mikhail Benet Rodríguez, Salim Berkinbayev ほか 678 名 - Nature Medicine 2023 被引用: 84

  8. Diabetes in Asia and the Pacific: Implications for the Global Epidemic

    著者: , , , , , , , - Diabetes Care 2016 被引用: 497

  9. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial

    著者: , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2013 被引用: 346

  10. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study

    著者: , , , , , , , , , , , , , , , , - Diabetes Obesity and Metabolism 2016 被引用: 274

  11. Trends in prevalence of diabetes in Asian countries

    著者: - World Journal of Diabetes 2012 被引用: 571

  12. Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

    著者: , , , , , , , , - Diabetologia 2020 被引用: 119

  13. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , - Diabetologia 2020 被引用: 81

  14. Diabetes in Asia

    著者: , , - The Lancet 2009 被引用: 775

  15. Know the signs and symptoms of diabetes.

    著者: - 2014 被引用: 148

  16. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey

    著者: , , , , , , , , , - Diabetologia 2001 被引用: 862

  17. Hypoglycemia: The neglected complication

    著者: , , , , , , , - Indian Journal of Endocrinology and Metabolism 2013 被引用: 253

  18. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2)

    著者: , , , , , , - Diabetologia 2009 被引用: 108

  19. Effectiveness of mobile phone text messaging in improving glycaemic control among persons with newly detected type 2 diabetes

    著者: , , , , , , - Diabetes Research and Clinical Practice 2019 被引用: 41

  20. Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , - Diabetologia 2012 被引用: 180

  21. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum

    著者: , , , , , , , , , , - Diabetes Care 2016 被引用: 146

  22. High Prevalence of Maturity-onset Diabetes of the Young (MODY) Among Indians

    著者: , , , , , - Diabetes Care 1985 被引用: 123

  23. Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial

    著者: , , , , , , , , , , , , , , , , , , , , , - American Heart Journal 2015 被引用: 106

  24. Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , - Diabetologia 2019 被引用: 80